Clinical Trials Directory

Trials / Completed

CompletedNCT06249815

Sequential Use of Foley's Catheter and Misoprostol Versus Misoprostol Alone for Induction of Labour: a Multicentre Randomised Controlled Trial

Sequential Use of Foley's Catheter and Low Dose Oral Misoprostol Versus Misoprostol Alone for Induction of Labour : a Multicentre Randomised Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
400 (actual)
Sponsor
Kazakhstan's Medical University "KSPH" · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

Evaluation of efficacy of inducing labour using a Foley's catheter and low dose oral misoprostol sequentially, in comparison with low dose oral misoprostol alone.

Detailed description

a multicentre, open-label randomised controlled trial in 2 hospitals in the Almaty,Kazakhstan. Women with a term singleton pregnancy in cephalic presentation, an unfavourable cervix, intact membranes, and without a previous caesarean section will be randomly allocated to 2 groups: 1 group -cervical ripening with Foley's catheter for 16 hour and sequentially 25 μg oral misoprostol once every 2 hour, 2 nd group- 25 μg oral misoprostol once every 2 hour. The primary outcome will be vaginal delivery within 24 hours(to evaluate effectiveness) and secondary outcoms 1-5-min Apgar score and hospitalization in ICU, rate of hyperstimulation ,hemorrage,chorioamnionitis (for evaluating safety)

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTMisoprostol 200mcg Tabranscervical Foley catheter (silicone, size 20F with 30ml balloon)+Misoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses
DRUGMisoprostol 200mcg TabMisoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses

Timeline

Start date
2024-04-26
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-02-08
Last updated
2025-02-21

Locations

2 sites across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT06249815. Inclusion in this directory is not an endorsement.